As expected, we also observed focal amplifications of MYCN and CDK4. Interestingly, the amplification of CDK4 was not retained in Rh-30R (relapse tumor paired with Rh-30; SNPs and STRs confirm identity). This evidence concerns the gene MYCN and neoplasm.